Hypercholesterolemia due to arg3500 mutation of Apo B-100

Hypercholesterolemia due to Arg3500 mutation of Apo B-100 is a genetic disorder characterized by an elevated level of cholesterol in the blood. This condition is specifically caused by a mutation at the arginine 3500 position of the Apolipoprotein B-100 (Apo B-100) gene. Apo B-100 is a critical protein involved in the metabolism of lipids, serving as a primary component of Low-Density Lipoprotein (LDL), often referred to as "bad" cholesterol. The Arg3500 mutation disrupts the normal function of Apo B-100, leading to an accumulation of LDL cholesterol in the bloodstream, a major risk factor for cardiovascular diseases, including heart attacks and strokes.

Causes

The Arg3500 mutation of Apo B-100 is a point mutation, meaning it involves the alteration of a single nucleotide base in the DNA sequence of the Apo B-100 gene. This mutation results in the substitution of arginine with another amino acid at the 3500th position of the Apo B-100 protein. The genetic change impairs the protein's ability to bind to LDL receptors on liver cells, hindering the clearance of LDL cholesterol from the blood.

Symptoms

Individuals with Hypercholesterolemia due to the Arg3500 mutation may not exhibit overt symptoms until the condition has progressed significantly. The primary manifestation of the disorder is hypercholesterolemia, specifically elevated levels of LDL cholesterol. Over time, the excessive cholesterol can deposit in the arterial walls, leading to atherosclerosis, a condition characterized by the hardening and narrowing of arteries. Symptoms related to atherosclerosis, such as chest pain (angina), may eventually develop.

Diagnosis

Diagnosis of Hypercholesterolemia due to the Arg3500 mutation of Apo B-100 typically involves a combination of lipid profiling, genetic testing, and family history. Lipid profiling can reveal elevated levels of LDL cholesterol, while genetic testing can confirm the presence of the Arg3500 mutation. A detailed family history may also indicate a pattern of inherited cholesterol-related disorders.

Treatment

Treatment for Hypercholesterolemia due to the Arg3500 mutation focuses on lowering LDL cholesterol levels and managing the risk of cardiovascular disease. This may include lifestyle modifications such as diet changes, physical activity, and weight management. Pharmacological interventions, particularly the use of statins, are often prescribed to reduce LDL cholesterol levels. In some cases, other lipid-lowering medications, such as ezetimibe or PCSK9 inhibitors, may be used in combination with statins.

Prevention

Preventive measures for individuals with a family history of Hypercholesterolemia due to the Arg3500 mutation include regular cholesterol screening and adopting a heart-healthy lifestyle from an early age. Early detection and management of elevated cholesterol levels can significantly reduce the risk of developing cardiovascular diseases.

Hypercholesterolemia due to arg3500 mutation of Apo B-100 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia